Sacroiliac Joint Fusion Market Analysis by Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma), by Treatment Type (Sacroiliac Joint Fusion Surgery, Sacroiliac Joint Fusion Injections, RF Sacroiliac Joint Fusion Ablation), by End User & Regional Forecast 2022-2032

Sacroiliac Joint Fusion Market Outlook (2022-2032)

The global sacroiliac joint fusion market size is estimated at US$ 620 Mn in 2022 and is likely to reach US$ 3,900 Mn by 2032. The market is expected to witness a CAGR of 20.2% during the forecast period from 2022 to 2032.

The growth of the market can be attributed to the rapid technical development in the healthcare sector and the growing demand for minimally invasive surgical procedures.

Revenue Analysis of Global Sacroiliac Joint Fusion Market 2015 to 2021 vs. Future Outlook 2022 to 2032

The global sacroiliac joint market is likely to have secured a market value of US$ 540 Mn in 2021. The market growth can be acknowledged to the increasing adoption of technologies and new materials for offering safer joint fusions, which comprises the usage of 3D-printed titanium implants and additive manufacturing.

The sacroiliac joint fusion is likely to witness a significant rise in the coming time. The growth of the market is attributed to the increasing demand for its less invasive nature and lower costs. As per Fact. MR, the global sacroiliac joint fusion market is projected to secure a market value of US$ 3,900 Mn by 2032, while recording a CAGR of 20.2% during the timeframe of 2022 t0 2032.

Why is Sacroiliac Joint Fusion Expected to Gain Traction during the Forecast Period?

Growing Demand for Minimally Invasive Surgeries to Fuel the Market

The increasing adoption of minimally invasive surgeries is anticipated to be the key factor driving the market during the forecast period. Further, the improving diagnostic capabilities for sacroiliac joint disorders and the adoption of new technologies are likely to offer better SI joint fusion systems.

In addition, the increasing geriatric population in developed countries like the US and the growing incidences of chronic diseases are anticipated to make a significant contribution in boosting the market. As per the 2019 data of the U.S Census Bureau, out of 328 million U.S population, about 75 Million were 60 years and above.

What is the Impact of COVID-19 on the Market?

The delayed elective surgeries hampered the market growth

The outbreak of COVID-19 resulted in reduced sales and low demand for the surgeries, thereby, hampering the market. The lockdown led to the postponement of elective surgeries and delayed clinical trials, taking the market graph down. The situation increased the need for innovation in healthcare facilities.

There was a tremendous rise in virtual medical services, however, various players faced losses.  For instance, SI-BONE disclosed that its operations ran at low resources owing to the reduced demand for its iFuse product. The loss incurred by the company was due to the restrictions imposed on elective procedures owing to the pandemic.

Region-wise Analysis

How is North America Providing Growth Opportunities for Sacroiliac Joint Fusion?

Growing Prevalence of Joint Pains is Likely to Widen Revenue Prospects

According to estimates by Fact.MR, North America is expected to account for 42% revenue in 2022 and beyond. The large share of the region can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Moreover, an increased incidence of joint pain is also widening growth prospects.

The National Center for Biotechnology Information reports that annual prevalence of low back pain among adults ranges from 15% to 45% among adults in the U.S. In response to this burden of disease, and in the hopes of improving outcomes, significant efforts have been made to better understand the various etiologies of back pain. In particular, increasing attention has recently been given to the SI joint as a pain generator, and estimates of low back pain attributable to the SI joint range by 15% to 30%.

Will Asia Pacific Open Lucrative Growth Opportunities for Sacroiliac Joint Fusion?

Elevated Healthcare Spending to Ease the Burden of Joint Pains Bolstering Prospects

Asia Pacific is forecast to register an impressive growth rate across the 2022-2032 forecast period, registering a CAGR of 17%. This growth can be attributed to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.

High health care spending, rise in the number of minimally invasive procedures performed in the region, and high adoption of advanced technologies by the population are expected to boost sacroiliac fusion implants market growth in the Asia Pacific.

Category-wise Insights

Which Indication of Sacroiliac Joint Fusion is likely to dominate?

Joint Fusions for Degenerative Sacroiliitis Likely to Reign Supreme

By indication, Fact.MR expects the degenerative sacroiliitis segment to accumulate 39% of the market revenue in 2022 and beyond. High prevalence rates of degenerative sacroiliitis and the consequent improvement in improving diagnostic and treatment capabilities is driving demand.

At the same time, sacroiliac joint fusion for trauma injuries is expected to pick up considerable pace across the forecast period. The use of SI joint fusion systems in trauma indications is one the most recently approved indications by the FDA, thus contributing to the high growth rate of this segment.

For which Treatment Category will Sacroiliac Joint Fusion Gain Momentum?

Sacroiliac Joint Fusion for Surgeries to Accumulate Maximum Revenue Share

Sacroiliac joint fusion surgeries will likely account for 40% revenue in 2022. The increasing preference for minimally invasive surgeries due to the associated benefits, such as smaller incisions, reduced pain & scarring, and faster recovery times, is the major factor contributing to the high share of this segment.

As patients increasingly demand trauma-free surgeries, hospitals and other healthcare settings are emphasizing on including minimally invasive surgical alternatives, leading to reduced pain.

Competitive Landscape

Prominent sacroiliac joint fusion service providers are emphasizing on a host expansion strategies, ranging from product development, new product launches, collaborations and acquisitions. Moreover, several players are also involved in offering clinical testing of their products and patent applications. Some prominent developments are as follows:

• In September 2021, PainTEQ was granted 3 patents in the U.S. for its drill-less method of stabilizing an SI joint, abrading device used in the procedure, and allograft implant respectively. All three offerings are used in the company’s minimally invasive LinQ procedure for SI joint dysfunction, thus solidifying PainTEQ’s position in the market.
• In June 2020, Orthofix Medical Inc. launched FIREBIRD SI Fusion System through a limited market release in the U.S. The system uses a 3D-printed titanium bone screw that is implanted through a minimally invasive surgery for treating SI joint dysfunction.

Sacroiliac Joint Fusion Market Report Scope

Key Segments Covered in the Sacroiliac Joint Fusion Market Report

• By Indication :

  • Joint Fusion for Degenerative Sacroiliitis
  • Joint Fusion for Sacral Disruption
  • Sacroiliac Joint Fusion for Trauma

• By Treatment Type :

  • Sacroiliac Joint Fusion Surgery
    • Surgery Type
      • Minimally Invasive Sacroiliac Joint Fusion Surgery
      • Open Sacroiliac Joint Fusion Surgery
    • Approach
      • Dorsal Sacroiliac Joint Fusion
      • Anterior Sacroiliac Joint Fusion
    • Product
      • Sacroiliac Joint Fusion Implants
      • Sacroiliac Joint Fusion Accessories
  • Sacroiliac Joint Fusion Injections
    • Diagnosis
    • Treatment
  • RF Sacroiliac Joint Fusion Ablation

• By End User :

  • Sacroiliac Joint Fusion in Hospitals
  • Sacroiliac Joint Fusion in Ambulatory Surgical Centers
  • Sacroiliac Joint Fusion for Other End Users (Specialty Centers and Research & Academic Institutes)